Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed with results

Key Signals

3 with results75% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (6)
P 1 (1)
P 3 (1)

Trial Status

Completed6
Unknown3
Terminated2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (11)

Research Network

Activity Timeline